For patients with resectable colorectal liver metastases (CRLM), the efficacy of adjuvant chemotherapy remains a subject of debate. Several studies have concluded that postoperative circulating tumor DNA (ctDNA) is a marker of minimal residual disease (MRD) and is a useful prognostic factor in patients with nonmetastatic colorectal cancer. However, few studies have explored its application in cases involving metastases. This was an observational study that included CRLM patients who underwent primary and liver tumor resection. By examining targeted sequencing of 50 genes commonly mutated in CRC, we identified at least one somatic mutation in each patient's metastatic liver tumor. Blood samples were obtained before and 1‐month after surgery. Fifty‐three patients were included, and recurrence was diagnosed in 39 patients. Of those, 13 patients experienced early relapse. ctDNA was detected in 45 patients before surgery and 11 after. All MRD‐positive patients experienced recurrence. Among them, nine had early recurrence. MRD‐positive patients had poorer recurrence free survival (RFS, p < 0.0001) and overall survival (OS, p < 0.0005). Nine of 13 patients with early recurrence had MRD; however, two of 40 patients without early recurrence also had MRD (p < 0.0001). Among 42 MRD‐negative patients, adjuvant chemotherapy had no impact of RFS (p = 0.84) or OS (p = 0.54). MRD proved valuable in predicting the risk of postoperative recurrence in patients with CRLM, particularly because MRD positivity emerged as a significant risk factor for early recurrence. Furthermore, it appears that adjuvant chemotherapy may not effectively improve the prognosis for MRD‐negative patients.
1 January 2026 in Asian Journal of Endoscopic Surgery
Background: While minimally invasive pancreaticoduodenectomy (MIPD) has become increasingly common, biliary reconstruction remains a formidable technical hurdle. Ensuring the reproducibility of hepaticojejunostomy, particularly when performed by procedure‐naïve surgeons, is a critical challenge. Methods: We retrospectively analyzed consecutive patients who underwent MIPD with laparoscopic hepaticojejunostomy using a standardized technique employing a handmade double‐armed suture. All procedures were performed by a procedure‐naïve U40 surgeon under expert supervision. The anastomotic safety and reconstruction time were evaluated to assess reproducibility. Results: A total of 23 patients were included. No bile leakage was observed, and anastomotic stricture occurred in 1 patient. The reconstruction time showed minimal variability throughout the series, indicating stable procedural performance from the early phase. Conclusion: A standardized laparoscopic hepaticojejunostomy technique can be safely and reproducibly performed by a procedure‐naïve surgeon with sufficient foundational experience under structured supervision. Technique‐based standardization may complement existing training strategies and facilitate sustainable dissemination of MIPD.
1 January 2026 in Asian Journal of Endoscopic Surgery
Purpose: Central pancreatectomy (CP) preserves pancreatic parenchyma but remains technically demanding in minimally invasive surgery because two pancreatic transection surfaces increase the risk of postoperative pancreatic fistula and hemorrhage. This study aimed to evaluate the feasibility of totally laparoscopic central pancreatectomy (LCP) using a standardized risk‐oriented surgical design, including a knotless continuous duct‐to‐mucosa pancreaticogastrostomy technique. Methods: This retrospective two‐institution study evaluated the feasibility of totally laparoscopic central pancreatectomy (LCP). A standardized risk‐oriented surgical design was adopted, consisting of stapler‐based pancreatic transection and duct‐to‐mucosa pancreaticogastrostomy for distal reconstruction. Open CP performed using the same reconstructive concept served as a reference cohort. Results: Six patients underwent CP, including three treated with totally laparoscopic CP. All laparoscopic procedures were completed without conversion. One patient developed clinically relevant postoperative pancreatic fistula (ISGPS grade B). No postpancreatectomy hemorrhage, reintervention, or mortality occurred. The median operative time and estimated blood loss in the laparoscopic group were 287 min and 10 mL, respectively. Conclusions: Totally laparoscopic central pancreatectomy appeared technically feasible in selected patients when performed within a standardized, risk‐oriented surgical framework.
20 February 2022 in Nihon Ika Daigaku Igakkai Zasshi
A 70-year-old man was admitted to our hospital with sudden hematochezia and an elastic, soft, reddish tumor measuring 40 mm in diameter prolapsed through the anus. The prolapsed tumor was manually repositioned, and subsequent computed colonography revealed it to be a villous tumor located in the sigmoid colon; it was diagnosed as a tubulovillous adenoma on biopsy. After the patient underwent bowel rest, elective laparoscopic resection was performed. The postoperative course was uneventful, and the patient was discharged 12 days after surgery. In this patient, the manual repositioning of the prolapsed tumor enabled effective bowel rest, which in turn meant that minimally invasive surgery could be performed. If it had not been possible to reposition the tumor, emergency surgery would have been unavoidable.